] . (2020). Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy. Neurology, 94(14), e1502-e1511. presented at the 2020 04 07. doi:10.1212/WNL.0000000000008687
. (2020). Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures. NPJ Vaccines, 5, 6. presented at the 2020. doi:10.1038/s41541-020-0156-y
. (2019). Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials. Front Med (Lausanne), 6, 122. presented at the 2019. doi:10.3389/fmed.2019.00122
. (2019). Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation. JAMA Oncol. presented at the 2019 Sep 26. doi:10.1001/jamaoncol.2019.2974
. (2019). Finding Common Ground and Advancing Engagement in Citizen Science. Narrat Inq Bioeth, 9(1), 41-45. presented at the 2019. doi:10.1353/nib.2019.0016
. (2019). Frailty in medically complex individuals with chronic HIV. AIDS, 33(10), 1603-1611. presented at the 2019 08 01. doi:10.1097/QAD.0000000000002250
. (2019). Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601. Biol Blood Marrow Transplant, 25(5), e174-e178. presented at the 2019 05. doi:10.1016/j.bbmt.2019.01.008
. (2017). Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial. Addiction, 112(6), 1036-1044. presented at the 2017 Jun. doi:10.1111/add.13753
. (2017). First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens. J Infect Dis, 215(1), 95-104. presented at the 2017 Jan 01. doi:10.1093/infdis/jiw500
. (2015). Fidelity Monitoring Model for an MI-Based Brief Intervention. In 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD). presented at the 13/06/2015, Phoenix, AZ. Retrieved from http://www.cpdd.org/
. (2014). First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002). J Infect Dis, 210, 1052-1061. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24719474
. (2014). First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). J Infect Dis, 210(7), 1052-61. presented at the 2014 Oct 01. doi:10.1093/infdis/jiu217
. (2013). Factors Influencing Adherence Behavior for Daily and Intermittent Regimens of Pre-Exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) in Kenya. In Adherence 2013. presented at the 02/06/2013, Miami, FL. Retrieved from http://www.iapac.org/AdherenceConference/Adherence_2013.html
. (2013). Factors Predicting Health Related Quality of Life in Pediatric Liver Transplant Recipients in the Functional Outcomes Group. Pediatr Transplant, 17, 605-611. presented at the 11/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23902630
. (2013). Factors predicting health-related quality of life in pediatric liver transplant recipients in the functional outcomes group. Pediatr Transplant, 17(7), 605-11. presented at the 2013 Nov. doi:10.1111/petr.12126
. (2013). Fetal Antiepileptic Drug Exposure: Adaptive and Emotional/Behavioral Functioning at Age 6 Years. Epilepsy Behav, 29, 308-315. presented at the 11/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24012508
. (2013). Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy Behav, 29(2), 308-15. presented at the 2013 Nov. doi:10.1016/j.yebeh.2013.08.001
. (2013). Fetal Antiepileptic Drug Exposure and Cognitive Outcomes at Age 6 Years (NEAD Study): A Prospective Observational Study. Lancet Neurol, 12, 244-252. presented at the 03/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23352199
. (2013). Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol, 12(3), 244-52. presented at the 2013 Mar. doi:10.1016/S1474-4422(12)70323-X
. (2013). Finding Your First Industry Job. In International Biometric Society - Eastern North American Region (ENAR). presented at the 10/05/2013, Orlando, FL. Retrieved from http://www.enar.org/
. (2013). First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J Infect Dis, 207(2), 240-7. presented at the 2013 Jan 15. doi:10.1093/infdis/jis670
. (2013). First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001). J Infect Dis, 207, 240-247. presented at the 01/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=23125444
. (2012). Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. Biol Blood Marrow Transplant, 18(7), 1007-11. presented at the 2012 Jul. doi:10.1016/j.bbmt.2012.04.014
. (2012). Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels. Biol Blood Marrow Transplant, 18, 1007-1011. presented at the 07/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22546497
. (2012). A framework for human microbiome research. Nature, 486(7402), 215-21. presented at the 2012 Jun 13. doi:10.1038/nature11209